Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients

被引:104
作者
Li, Yuan-Hong [1 ]
Chen, John Z. S. [2 ]
Wei, Hua-Chen [1 ,3 ]
Wu, Yan [1 ]
Liu, Mei [1 ]
Xu, Yuan-Yuan [1 ]
Dong, Guang-Hui [4 ]
Chen, Hong-Duo [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Peoples R China
[2] Sheftel Associates Dermatol, Tucson, AZ USA
[3] Mt Sinai Med Ctr, Dermatol Res Labs, Dept Dermatol, New York, NY 10029 USA
[4] China Med Univ, Dept Biostat, Shenyang, Peoples R China
关键词
D O I
10.1111/j.1524-4725.2008.34130.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
BACKGROUND Melasma is commonly seen in the Asian population. Traditional therapies are less effective and may cause adverse effects. OBJECTIVE The objective was to study the efficacy and safety of a new intense pulsed light (IPL) device in the treatment of melasma in Chinese patients. METHODS Eighty-nine women with melasma were enrolled in this open-labeled study. Subjects received a total of four IPL treatments at 3-week intervals. Changes in facial hyperpigmentation and telangiectasis were evaluated using an objective, skin colorimeter (Mexameter, Courage & Khazaka), the melasma area and severity index (MASI), and a global evaluation by the patients and blind investigators. RESUTS Sixty-nine of 89 patients (77.5%) obtained 51% to 100% improvement, according to the overall evaluation by dermatologists. Self-assessment by the patients indicated that 63 of 89 patients (70.8) considered more than 50% or more improvement. Mean MASI scores decreased substantially from 15.2 to 4.5. Mexameter results demonstrated a significant decrease in the degree of pigmentation and erythema beneath the melasma lesions. Patients with the epidermal-type melasma responded better to treatment than the mixed type. Adverse actions were minimal. CONCLUSION IPL treatment is a good option for patients with melasma. Adverse actions of IPL were minimal and acceptable.
引用
收藏
页码:693 / 701
页数:9
相关论文
共 12 条
[1]
Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma:: Split-face design [J].
Angsuwarangsee, S ;
Polnikorn, N .
DERMATOLOGIC SURGERY, 2003, 29 (01) :59-64
[2]
Development and validation of a health-related quality of life instrument for women with melasma [J].
Balkrishnan, R ;
McMichael, AJ ;
Camacho, FT ;
Saltzberg, F ;
Housman, TS ;
Grummer, S ;
Feldman, SR ;
Chren, MM .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (03) :572-577
[3]
LASER TREATMENT OF BENIGN PIGMENTED EPIDERMAL LESIONS USING A 300 NSECOND PULSE AND 510 NM WAVELENGTH [J].
FITZPATRICK, RE ;
GOLDMAN, MP ;
RUIZESPARZA, J .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1993, 19 (04) :341-347
[4]
MELASMA - ETIOLOGIC AND THERAPEUTIC CONSIDERATIONS [J].
GRIMES, PE .
ARCHIVES OF DERMATOLOGY, 1995, 131 (12) :1453-1457
[5]
RUBY-LASER TREATMENT OF MELASMA AND POSTINFLAMMATORY HYPERPIGMENTATION [J].
HOHENLEUTNER, U .
DERMATOLOGIC SURGERY, 1995, 21 (11) :994-994
[6]
Erbium:YAG laser resurfacing for refractory melasma [J].
Manaloto, RMP ;
Alster, T .
DERMATOLOGIC SURGERY, 1999, 25 (02) :121-123
[7]
Study of the incidence and nature of "very subtle epidermal melasma" in relation to intense pulsed light treatment [J].
Negishi, K ;
Kushikata, N ;
Tezuka, Y ;
Takeuchi, K ;
Miyamoto, E ;
Wakamatsu, S .
DERMATOLOGIC SURGERY, 2004, 30 (06) :881-886
[8]
Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser:: A pilot study [J].
Nouri, K ;
Bowes, L ;
Chartier, T ;
Romagosa, R ;
Spencer, J .
DERMATOLOGIC SURGERY, 1999, 25 (06) :494-497
[9]
The treatment of melasma with fractional photothermolysis: A pilot study [J].
Rokhsar, CK ;
Fitzpatrick, RE .
DERMATOLOGIC SURGERY, 2005, 31 (12) :1645-1650
[10]
INEFFECTIVE TREATMENT OF REFRACTORY MELASMA AND POSTINFLAMMATORY HYPERPIGMENTATION BY Q-SWITCHED RUBY-LASER [J].
TAYLOR, CR ;
ANDERSON, RR .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1994, 20 (09) :592-597